Blood Coagulation Tests Clinical Trial
Official title:
A Prospective Pharmacodynamic Study of Dabigatran Using Peak and Trough Coagulation Test Results in Patients on Therapeutic Doses of Dabigatran
The ability to explain bleeding or clotting complications in patients treated with dabigatran remains challenging. In addition, there is limited data on how coagulation tests perform in patients treated with therapeutic doses of dabigatran. Predicted responses of coagulation tests to therapeutic doses of dabigatran may be helpful in better understanding abnormal responses to dabigatran. The purpose of the study is to define a therapeutic reference range for peak and trough coagulation tests in patients taking FDA approved doses of dabigatran and to determine which tests may be most clinically useful for monitoring dabigatran.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03647254 -
Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study)
|
N/A | |
| Unknown status |
NCT02255214 -
Evaluation of the Accuracy of the Hemochron Signature Elite Point of Care Device Compared With Laboratory Assay
|
N/A | |
| Completed |
NCT03280368 -
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
|
||
| Recruiting |
NCT01167660 -
Non Invasive Measurement of Coagulation in Term and Preterm Neonates
|
N/A | |
| Terminated |
NCT02839434 -
Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy
|